Decision: Favourable

Study Title:

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Examine the Efficacy and Safety of ZX008 in Subjects with CDKL5 Deficiency Disorder Followed by an Open-Label Extension

  • NREC Code:


  • Decision:


  • Meeting Date:


  • Study Type:

    CT application

  • Principal Investigator:

    Dr. Kathleen Gorman

  • PI Institution:

    Children's Health Ireland at Temple Street

  • Sponsor:

    Zogenix International Limited

Scroll to Top